Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levobupivacaine dose reduction for interscalene brachial plexus block in arthroscopic shoulder surgery
2019-003855-12Phase 3Active
- Sponsor
- IIS Aragón
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of levobupivacaine in postoperative pain (2 arms), sponsored by IIS Aragón. Primary endpoints: Incidence of acute diaphragmatic paralysis diagnosed by ultrasound and Maintenance of postoperative analgesia. Started Dec 2019; status: active.
02
Drugs
levobupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2019-003855-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003855-12.